Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Kiyotaka Kawauchi"'
Autor:
Toshie Ogasawara, Kiyotaka Kawauchi, Takuya Ono, Shoko Marshall, Kotaro Shide, Kazuya Shimoda, Naoki Mori, Hiroshi Sakura
Publikováno v:
Leukemia Research Reports, Vol 13, Iss , Pp 100194- (2020)
Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm (MPN) with a transformation to acute myeloid leukemia in
Externí odkaz:
https://doaj.org/article/86621ed111a34cee801160f5d3d2da8e
Publikováno v:
Hematology Reports, Vol 4, Iss 2, Pp e11-e11 (2012)
A 68-year old woman came to our hospital with a severe case of anemia. Serum immunoelectropheresis identified a monoclonal immunoglobulin (Ig) G and κ protein. The serum IgE level was within the nomal range and the amounts of remaining immuno - glob
Externí odkaz:
https://doaj.org/article/199660c2c0914f258cacc75c5668b4e0
Autor:
Osamu Yamada DR., Masaharu Akiyama, Kiyotaka Kawauchi, Tomoko Adachi, Hisashi Yamada, Naotoshi Kanda, Eizo Aikawa
Publikováno v:
Cell Transplantation, Vol 12 (2003)
Leukemic stem cells that expressed endogenous telomerase activity were induced to show overexpression of exogenous hTERT and were analyzed for biological changes in order to assess the possible influence of telomerase gene therapy on the transplantat
Externí odkaz:
https://doaj.org/article/7c200968985f4d94a069967e70afc159
Autor:
Toshie, Ogasawara, Nozomiko, Ebata, Julia, Hamasaki, Shoko, Marshall, Kiyotaka, Kawauchi, Koichi, Ohshima, Naoki, Mori, Hiroshi, Sakura
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 60(6)
Primary adrenal lymphoma is a rare lymphoma, accounting for0.2% of non-Hodgkin lymphoma. The leading histopathological subtype of adrenal lymphoma is diffuse large B-cell lymphoma, and intravascular large B-cell lymphoma (IVLBCL) is rare. Here, we re
Autor:
Naoya Kojima, Kiyotaka Kawauchi, Yasuhiro Kuroda, Shohei Kojima, Yuko Matsuoka, Yoko Kawauchi, Akari Takiyama
Publikováno v:
Glycoconjugate journal. 36(3)
In this study, we assessed the potential of liposomes coated with a neoglycolipid containing α1-3,α1-6-mannotriose residues (Man3-DPPE; Manα1-6(Manα1-3)Manitol-DPPE) for in vitro activation and maturation of human mononuclear phagocytes. In respo
Autor:
Takuya Ono, Kiyotaka Kawauchi, Shoko Marshall, Toshie Ogasawara, Naoki Mori, Hiroshi Sakura, Kotaro Shide, Kazuya Shimoda
Publikováno v:
Leukemia Research Reports, Vol 13, Iss, Pp 100194-(2020)
Leukemia Research Reports
Leukemia Research Reports
Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm (MPN) with a transformation to acute myeloid leukemia in
Autor:
Hiroshi Sakura, Motohiko Aiba, Kiyotaka Kawauchi, Toshie Ogasawara, Masabumi Shibuya, Tsutomu Sanaka, Mariko Fujibayashi
Publikováno v:
European Journal of Haematology. 96:144-151
Primary effusion lymphoma (PEL) is a rare B-cell lymphoma subtype that is characterized by lymphomatous effusion without the presence of masses, and it typically occurs in human immunodeficiency virus (HIV)-infected individuals. Lymphoma cells are un
Autor:
Toshie, Ogasawara, Kiyotaka, Kawauchi, Naoki, Mori, Hiroshi, Sakura, Fumiyo, Katoh, Hitoshi, Kanno, Etsuro, Ito
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(8)
Diamond-Blackfan anemia (DBA) is a rare congenital disease caused by mutations in ribosomal protein genes and is characterized by pure red cell aplasia. While the prognosis is relatively favorable, quality of life (QOL) among DBA patients is negative
Publikováno v:
Journal of Cancer Research & Therapy, Vol 1, Iss 4, Pp 138-142 (2013)
This report describes a case of a patient who developed therapy-related acute myeloid leukemia five years after initiating chemotherapy for follicular lymphoma. The patient had been treated with multiple chemotherapeutic regimens, including anthracyc
Publikováno v:
Molecular Cancer Therapeutics. 11:1112-1121
Adult T-cell leukemia (ATL) is a heterogeneous tumor that is resistant to chemotherapy. Telomerase activity plays a critical role in tumorigenesis and is associated with the prognosis of ATL patients. Interleukin (IL)-2 commonly promotes tumor growth